Bayer has entered a collaboration with MOMA Therapeutics in which the two companies will advance a small molecule oncology ...

The MHRA’s 2024/25 business plan focuses on improving service delivery for its customers, enabling access to new technologies ...

The Phase III trials will evaluate survodutide in metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and ...

Innovent Biologics and ASK Pharm have signed a strategic partnership for the commercialisation of limertinib for the ...

The long-acting injectable PrEP option is being rolled out at a record pace in sub-Saharan Africa and lower-income countries.

The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of ...

NP001 is designed to tackle the neurodegenerative disease through an immunologic mechanism as opposed to a neurologic one.

The company intends to start a registrational Phase II trial of pelareorep and chemotherapy combination for breast cancer in ...

OnKure has announced the successful completion of its merger with Reneo Pharmaceuticals, with the combined entity set to ...

The CD7 CAR)-T cell therapy has demonstrated potential in treating patients with relapsed or refractory T-cell leukaemia.

ProductLife Group (PLG) has announced the acquisition of IntiQuan, a Swiss firm specialising in pharmacometrics.

Health Canada has expanded the approved use of Telix Pharmaceuticals' Illuccix for patient selection in PSMA targeted ...